Table 1 Clinicopathological characteristics of 879 patients with resectable hepatocellular carcinoma
From: Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma
| Â | Number of patients (%) or median (25-75 percentile) |
|---|---|
Age (years) | 58 (47-66) |
Male/female | 707 (80.4)/172 (19.6) |
Hepatitis B virus positive, hepatitis C virus positive | 549 (66.7), 285 (38.5) |
CTP status: A/B or C | 821 (93.4)/58 (6.6) |
ICG retention rate at 15 min (%) | 9.7 (5.7-16.4) |
Albumin (g/dL) | 4.1 (3.8-4.4) |
Bleeding (> 500 mL) | 401 (45.9) |
Mortality | 35 (4.0) |
AFP (ng/mL) | 66.8 (9.7-770.0) |
Tumor size (cm) | 4.0 (2.5-7.0) |
Rupture | 53 (6.0) |
Cirrhosis | 507 (57.7) |
Macro/microvascular invasion | 188 (21.4)/104 (11.8) |
Satellite lesions | 229 (26.1) |
Encapsulation | 627 (71.3) |
Resection margin positive | 37 (4.2) |
Grade | 432 (49.1)/447 (50.9) |
Well and moderate differentiated/poorly and undifferentiated | Â |